The global erythropoietin (EPO) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to boost the global erythropoietin market includes rise in prevalence of anemic conditions induced from end stage renal disease treatment, chemotherapy, and antiretroviral treatment (ART). Hence, rise in number of treatment cycles for chemotherapy and rising incidences of end stage renal diseases (dialysis) has increased the demand for EPO drugs. Side effects associated with EPO including arterial hypertension, iron deficiency, and influenza-like syndrome and longer duration of EPO treatment (4-6 weeks) restrain growth of the erythropoietin drugs market. Moreover, rise in trends of commercialization of EPO biosimilars, readily available reimbursements, favorable government regulations, and increase in level of awareness regarding benefits of EPO therapeutics are some factors that are expected to fuel the growth of the erythropoietin drugs market during the forecast period. EPO/hematopoietin is a glycoprotein hormone that triggers production of red blood cells in the bone marrow through erythropoiesis. Erythropoietin drug was developed with the objective to treat anemic conditions caused by end stage renal disease (ESRD) disease treatments and dialysis procedures. Followed by ESRD anemic condition, EPO drugs have gained approvals for chemotherapy-induced anemia.

To Request a Sample of our Report on Erythropoietin Market:   https://www.omrglobal.com/request-sample/erythropoietin-market

After post-abbreviated new drug application (ANDA) approvals and high success rate of EPO applications for chemotherapy-induced anemia, biopharmaceutical companies turned their attention to another form of induced anemia, namely ART-induced anemia (among HIV patients). Currently, scientists are planning a randomized clinical trial to systematically investigate effects of treating COVID-19 using erythropoietin. It is a hormone/cytokine produced mainly by kidneys via hypoxia inducible factor-2 as its primary transcription factor and through inhibition of apoptosis of RBC precursors. However, EPO has other beneficial cytoprotective effects including anti-ischemic, regenerative, and anti-apoptotic effects in a variety of tissues including lung, kidney, cardiac muscle, nervous system, retina, pancreas, and endothelial cells. Through a special receptor; EPOR-?cR, it conducts its protective effects following trauma in critically ill patients. Thus, impact of COVID-19 pandemic is expected to remain positive for key players in the global erythropoietin market.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027

Segment Covered- 

  • By Drug Class
  • By Product Type
  • By Application

Regions covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape: Amgen Inc., Johnson & Johnson Services, Inc., and F. Hoffman La-Roche AG, among others.

(Get 15% Discount on Buying this Report)

A full Report of Erythropoietin Market is Available @ https://www.omrglobal.com/industry-reports/erythropoietin-market

Global Erythropoietin Market Report by Segment

By Drug Class 

  • Biologics
  • Biosimilars

By Product Type

  • Epoetin-Alfa
  • Epoetin-Beta
  • Darbepoetin-Alfa
  • Others

By Application

  • Hematology
  • Cancer
  • Kidney Disorder
  • Others

Global Erythropoietin Market Report by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of the World

  • Latin America
  • Middle East & Africa

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404